Key result
Women treated with drug-coated balloons for de novo coronary artery disease had higher late lumen loss at 6 months compared to men, though long-term clinical outcomes were similar.
Why the study?
Although drug-coated balloon treatment is effective for de novo lesions, the influence of sex on angiographic and clinical outcomes remains unknown.
Does sex influence angiographic and clinical outcomes in patients with de novo coronary lesions treated with drug-coated balloons?
Cohort (n=227)
Yes
Does sex influence angiographic and clinical outcomes in patients with de novo coronary lesions treated with drug-coated balloons?
Answers are grounded in this paper and cite their sources.
In patients treated with drug-coated balloons for de novo coronary lesions, female sex is an independent predictor of higher late lumen loss at 6 months, but this does not appear to increase the risk of target vessel failure.
PURPOSE: Although drug-coated balloon (DCB) treatment is known to be effective for de novo lesions, the influence of sex on angiographic and clinical outcomes remains unknown. This study aimed to investigate the angiographic and clinical impact of DCB treatment in patients with de novo coronary lesions according to sex. MATERIALS AND METHODS: A total of 227 patients successfully treated with DCB were retrospectively enrolled and divided into two groups according to sex. The primary endpoint was late lumen loss (LLL) at 6-month angiography, and the secondary endpoint was target vessel failure (TVF), which included cardiac death, target vessel myocardial infarction, target lesion revascularization, and target vessel thrombosis. In multivariable analysis, women were independently associated with a higher LLL. CONCLUSION: LLL was higher in women, but there was no difference in TVF between women and men. Based on multivariable analysis, the women sex was an independent predictor of higher LLL (Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion; NCT04619277).
No takes yet. Share an insight, caveat, or question.
K et al. (2021) conducted a cohort in De novo coronary artery disease (n=227). Female sex vs. Male sex was evaluated on Late lumen loss (LLL) at 6-month angiography (p=0.012). Women treated with drug-coated balloons for de novo coronary artery disease had higher late lumen loss at 6 months compared to men, though long-term clinical outcomes were similar.
Synapse has enriched 10 related papers. Consider them for comparative context: